SARS-CoV-2 seroprevalence in Spain - Authors' reply

Affiliations

¹ National Centre for Epidemiology, Institute of Health Carlos III, 28029 Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health, Institute of Health Carlos III, 28029 Madrid, Spain. Electronic address: mpollan@isciii.es.
² National Centre for Epidemiology, Institute of Health Carlos III, 28029 Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health, Institute of Health Carlos III, 28029 Madrid, Spain.
³ National Centre for Microbiology, Institute of Health Carlos III, 28029 Madrid, Spain; Spanish Network for Research in Infectious Diseases, Institute of Health Carlos III, 28029 Madrid, Spain.
⁴ National Centre for Microbiology, Institute of Health Carlos III, 28029 Madrid, Spain.
⁵ Directorate, Institute of Health Carlos III, 28029 Madrid, Spain.

Comment

Marina Pollán et al. Lancet. 2020.

. 2020 Nov 7;396(10261):1484-1485.

doi: 10.1016/S0140-6736(20)32266-2.

¹ National Centre for Epidemiology, Institute of Health Carlos III, 28029 Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health, Institute of Health Carlos III, 28029 Madrid, Spain. Electronic address: mpollan@isciii.es.
² National Centre for Epidemiology, Institute of Health Carlos III, 28029 Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health, Institute of Health Carlos III, 28029 Madrid, Spain.
³ National Centre for Microbiology, Institute of Health Carlos III, 28029 Madrid, Spain; Spanish Network for Research in Infectious Diseases, Institute of Health Carlos III, 28029 Madrid, Spain.
⁴ National Centre for Microbiology, Institute of Health Carlos III, 28029 Madrid, Spain.
⁵ Directorate, Institute of Health Carlos III, 28029 Madrid, Spain.

No abstract available

Comment on

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
Pollán M, Pérez-Gómez B, Pastor-Barriuso R, Oteo J, Hernán MA, Pérez-Olmeda M, Sanmartín JL, Fernández-García A, Cruz I, Fernández de Larrea N, Molina M, Rodríguez-Cabrera F, Martín M, Merino-Amador P, León Paniagua J, Muñoz-Montalvo JF, Blanco F, Yotti R; ENE-COVID Study Group. Pollán M, et al. Lancet. 2020 Aug 22;396(10250):535-544. doi: 10.1016/S0140-6736(20)31483-5. Epub 2020 Jul 6. Lancet. 2020. PMID: 32645347 Free PMC article.

1. Pollán M, Pérez-Gómez B, Pastor-Barriuso R. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet. 2020;396:535–544. - PMC - PubMed
1. CNE/RENAVE Informe sobre la situación de COVID-19 en España. 2020. https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/...
1. Nova IP. Radiografía del papel de la mujer en la sanidad española. Redacción Médica. March, 2018. https://www.redaccionmedica.com/secciones/sanidad-hoy/radiografia-del-pa...
1. Metcalf CJE, Farrar J, Cutts FT. Use of serological surveys to generate key insights into the changing global landscape of infectious disease. Lancet. 2016;388:728–730. - PMC - PubMed
1. Long Q-X, Liu B-Z, Deng H-J. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020;26:845–848. - PubMed